via The Scientist RSS https://ift.tt/2X6QQZY A new platform enables screening a wide range of combination anticancer therapeutics in a matter of days, which may translate to personalized therapeutic regimens for patients in less time. https://ift.tt/eA8V8J September 10, 2021 at 11:19PM